Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study
Crossref DOI link: https://doi.org/10.1007/s12094-022-03020-5
Published Online: 2022-12-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cui, Yuzhong
Huang, Wei
Du, Feng
Yin, Xiaoyang
Feng, Lei
Li, Baosheng http://orcid.org/0000-0003-3564-9240
Text and Data Mining valid from 2022-12-06
Version of Record valid from 2022-12-06
Article History
First Online: 6 December 2022